Subscribe
eNewsletter
Ready to get certified?
Free CDCES Coach App
Download
Free Med Pocket Cards
eNewsletter
Free CDCES Coach App
Free Med Pocket Cards
Author: Sarah Hormachea, MS, RD, CDCES, BC-ADMDiabetes Care and Education, LLC If you subscribe to the CBDCE listserv, you probably noticed a recent email announcing exploration of a new credential … Continue reading Beyond the CDCES: A New Credential for Diabetes Support Staff Is on the Horizon
JL has T2DM, and heart failure with preserved ejection fraction (HFpEF). Is currently on Metformin 1000mg BID and empagliflozin 25mg daily. Their A1C is 8.1%. Which agent should be added … Continue reading Question of the Week | What’s the best medication for HFpEF?
For last week’s practice question, we quizzed participants on who would most benefit from metformin therapy. 63.26% of respondents chose the best answer. We want to clarify and share this … Continue reading Rationale of the Week | Who would most benefit from metformin therapy?
A 16-year-old with Type 1 Diabetes uses a CGM and has a Time in Range (70-180 mg/dL) of 72%, but their GMI (Glucose Management Indicator) is 7.4% and they report … Continue reading Question of the Week | A1C 7.4% & Struggling with Hypoglycemia
For last week’s practice question, we quizzed participants on applying the quadruple aim. 91% of respondents chose the best answer. We want to clarify and share this important information, so … Continue reading Rational of the Week | Target of the Quadruple Aim?
By Christine Craig, MS, RDN, CDCESFounder: Nutrition for Daily Living Recognizing the importance of comprehensive cardiovascular risk assessment, this article narrows in to review the newly recognized lipid screening strategies … Continue reading Beyond LDL: Decoding Lipids, Lipoproteins & More
Which individual with prediabetes would derive the greatest long-term benefit from the initiation of metformin therapy according to the Diabetes Prevention Program (DPP) outcomes? A. A 72-year-old male with a … Continue reading Question of the Week | Who would most benefit from metformin therapy?
For last week’s practice question, we quizzed participants on the role of diabetes HCPs in addressing psychosocial needs. 95% of respondents chose the best answer. We want to clarify and … Continue reading Rationale of the Week | The role of CDCES in addressing psychosocial needs